Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645807) titled 'An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram' on June 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Sichuan Credit Pharmaceutical Co., Ltd.

Condition: Adjunct in the Treatment of Depressive Disorder

Intervention: Combination Product: Escitalopram (...